WASHINGTON - Safety concerns with the popular birth-control pill Yaz increased Thursday as federal health scientists reported that the Bayer drug and other newer birth-control treatments appear to ...

No rest for the Food and Drug Administration (FDA) this week. In addition to considering broadened access to the emergency contraceptive Plan B, an FDA panel decided on Thursday to update labeling on ...

Yaz, Yasmin and other newer birth control pills will soon be bearing warning labels that detail the potential risk of blood clot risks, the U.S. Food and Drug Administration (FDA) announced on Tuesday ...

Watson, Bayer in patent lawsuit over Yaz Yaz had U.S. sales of $173 mln for year ended Sept. 30 Nov 29 (Reuters) - Watson Pharmaceuticals Inc said it received U.S. regulatory approval for a generic ...

A new study finds that oral contraceptives appear to change an important part of the brain, but experts say the results aren't "game-changing." People are calling for a boycott of CVS after the ...

Bayer is adding two of its name-brand drugs to the roster of Cost Plus Drugs: the birth control pill Yaz and the menopause treatment Climara. Bayer is the latest name-brand drugmaker to dip its toe ...